Published July, 2019
By Kate B. Daigle
Publisher: Taylor & Francis (Routledge)
Rating: 1.00
Availability: Available

This book is a comprehensive guide to addressing, working with, and healing from emotional struggles related to fertility and eating disorders.The only book of its kind, it will be useful to practitioners, therapists, and scholars alike.

---

Published July, 2019
By Cheryl Fuller
Publisher: Taylor & Francis (Routledge)
Rating:
Availability: Available

This book examines the so-called War on Obesity as an example of a cultural complex, how that complex shapes the way fat is treated in psychotherapy, including the classical Jungian approach to fat, as written by Marion Woodman. It looks at the experience of being fat as an ongoing trauma.

---

Published July, 2019
By Giorgio Nardone, Roberta Milanese and Tiziana Verbitz
Publisher: Taylor & Francis (Routledge)
Rating:
Availability: Available

This groundbreaking volume concentrates on solution-oriented treatment of some of the most difficult pathologies - anorexia, bulimia and vomiting. The logic and apparent simplicity of the way these complex conditions are treated is truly outstanding.

---

Published July, 2019
By Kelly G. Wilson, Rhonda M. Merwin, Nancy L. Zucker, Lisa K. Honeycutt and Ashley A. Moskovich
Publisher: Taylor & Francis (Guilford Press)
Rating: 1.00
Availability: Available

This is the first book to present a roadmap for tailoring acceptance and commitment therapy (ACT) to the serious, complex challenges of anorexia nervosa (AN). Leading authorities describe interventions grounded in ACT core processes

---

Published June, 2019
By C. Laird Birmingham and Janet Treasure
Publisher: Cambridge University Press
Rating:
Availability: Available

Now in its third edition, the Medical Management of Eating Disorders explores the diagnosis and general management of eating disorders. Featuring up-to-date research on world-class treatments, this book helps health care professionals understand how to treat eating disorders and subsequent medical complications that arise.

---

Published June, 2019
By Michael S. Freemark
Publisher: Springer (Birkhauser Verlag AG)
Rating:
Availability: Available

This second edition of Freemark's text embodies all of the strengths of the original work but is deeper and broader in scope, with new chapters on emerging themes including metabolomics, genomics, and the roles of gastrointestinal hormones, the microbiome, brown adipose tissue, and endocrine disruptors in the pathogenesis of childhood obesity.

---

Published May, 2019
By Niva Piran and Tracy L. Tylka
Publisher: Oxford University Press (Oxford University Press Inc)
Rating:
Availability: Available

---

Published May, 2019
By Glenn Waller, Victoria Mountford, Tracey Wade, Tracey D. Wade, Glen Waller, Hannah Turner, Madeleine Tatham, Victoria A Mountford and Hannah M. Turner
Publisher: Taylor & Francis (Routledge)
Rating:
Availability: Available

Brief Cognitive Behavioural Therapy for Non-Underweight Patients provides an evidence-based protocol that can be delivered by junior or senior clinicians, helping patients to recover and go on to live a healthy life.

---

Published May, 2019
By Glenn Waller, Victoria Mountford, Tracey Wade, Tracey D. Wade, Glen Waller, Hannah Turner, Madeleine Tatham, Victoria A Mountford and Hannah M. Turner
Publisher: Taylor & Francis (Routledge)
Rating:
Availability: Available

Brief Cognitive Behavioural Therapy for Non-Underweight Patients provides an evidence-based protocol that can be delivered by junior or senior clinicians, helping patients to recover and go on to live a healthy life.

---

Published April, 2019
By Andrew J. Krentz, Marcus Hompesch and Christian Weyer
Publisher: Springer (Springer Nature Switzerland AG)
Rating: 1.00
Availability: Available

This book aims to aid the selection of the most appropriate methods for use in early phase (1 and 2) clinical studies of new drugs for diabetes, obesity, non-alcoholic fatty liver disease (NAFLD) and related cardiometabolic disorders. Clinical research methods to assess the pharmacokinetics and pharmacodynamics of new diabetes drugs, e.g.

---